Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raquelle Mesholam-Gately, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mesholam-Gately RI, Johnston D, Keshavan MS. What's in the name "schizophrenia"? A clinical, research and lived experience perspective. World Psychiatry. 2023 Feb; 22(1):156-157. PMID: 36640406; PMCID: PMC9840481.
    Citations:    
  2. Schutt RK, Xie H, Mueser KT, Killam MA, Delman J, Eack SM, Mesholam-Gately R, Pratt SI, Sandoval L, Santos MM, Golden LR, Keshavan MS. Correction: Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation. BMC Psychiatry. 2022 Sep 16; 22(1):613. PMID: 36114520; PMCID: PMC9479309.
    Citations:    Fields:    
  3. Schutt RK, Xie H, Mueser KT, Killam MA, Delman J, Eack SM, Mesholam-Gately R, Pratt SI, Sandoval L, Santos MM, Golden LR, Keshavan MS. Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation. BMC Psychiatry. 2022 09 01; 22(1):583. PMID: 36050663; PMCID: PMC9434502.
    Citations: 1     Fields:    Translation:Humans
  4. Seitz-Holland J, Wojcik JD, Cetin-Karayumak S, Lyall AE, Pasternak O, Rathi Y, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz BA, Schretlen DA, Viher PV, Stegmayer K, Walther S, Lee J, Crow T, James A, Voineskos A, Buchanan RW, Szeszko PR, Malhotra AK, Kelly S, Shenton ME, Keshavan MS, Mesholam-Gately RI, Kubicki M. Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study. Mol Psychiatry. 2022 09; 27(9):3719-3730. PMID: 35982257.
    Citations: 1     Fields:    Translation:Humans
  5. Flores AT, Hogarty SS, Mesholam-Gately RI, Barrio C, Keshavan MS, Eack SM. Cognitive gains as a mechanism of functional capacity improvement in schizophrenia: Results from a multi-site randomized controlled trial. J Psychiatr Res. 2022 07; 151:554-560. PMID: 35636031.
    Citations:    Fields:    Translation:Humans
  6. Weiss DM, Bernier E, Robbins DR, Elacqua KM, Johnson KA, Powers K, Mesholam-Gately RI, Woodberry KA. Using Experience Sampling Methodology Data to Characterize the Substance Use of Youth With or At-Risk of Psychosis. Front Psychiatry. 2022; 13:874246. PMID: 35599768; PMCID: PMC9116148.
    Citations:    
  7. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fañanás L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, González Peñas J, González-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Gülöksüz S, Gur RE, Gur RC, Gutiérrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julià A, Kähler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kucinskas V, Kucinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lönnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntané G, Murphy KC, Myin-Germeys I, Nenadic I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O'Brien NL, O'Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietiläinen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Söderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stögmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Üçok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbasoglu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 04; 604(7906):502-508. PMID: 35396580; PMCID: PMC9392466.
    Citations: 159     Fields:    Translation:Humans
  8. Di Biase MA, Geaghan MP, Reay WR, Seidlitz J, Weickert CS, Pébay A, Green MJ, Quidé Y, Atkins JR, Coleman MJ, Bouix S, Knyazhanskaya EE, Lyall AE, Pasternak O, Kubicki M, Rathi Y, Visco A, Gaunnac M, Lv J, Mesholam-Gately RI, Lewandowski KE, Holt DJ, Keshavan MS, Pantelis C, Öngür D, Breier A, Cairns MJ, Shenton ME, Zalesky A. Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia. Mol Psychiatry. 2022 04; 27(4):2052-2060. PMID: 35145230; PMCID: PMC9126812.
    Citations: 3     Fields:    Translation:HumansCells
  9. van Gool KCA, Collin G, Bauer CCC, Molokotos E, Mesholam-Gately RI, Thermenos HW, Seidman LJ, Gabrieli JDE, Whitfield-Gabrieli S, Keshavan MS. Altered working memory-related brain activity in children at familial high risk for psychosis: A preliminary study. Schizophr Res. 2022 02; 240:186-192. PMID: 35032903.
    Citations:    Fields:    Translation:Humans
  10. Keshavan MS, Davis B, Friedman-Yakoobian M, Mesholam-Gately RI. What is my diagnosis, Doc?: Discussing psychosis diagnosis with patients and families. Schizophr Res. 2022 01; 239:92-94. PMID: 34864440.
    Citations: 1     Fields:    Translation:Humans
  11. Mesholam-Gately RI, Varca N, Spitzer C, Parrish EM, Hogan V, Behnke SH, Larson L, Rosa-Baez C, Schwirian N, Stromeyer C, Williams MJ, Saks ER, Keshavan MS. Are we ready for a name change for schizophrenia? A survey of multiple stakeholders. Schizophr Res. 2021 12; 238:152-160. PMID: 34688117.
    Citations: 3     Fields:    Translation:Humans
  12. Wojtalik JA, Mesholam-Gately RI, Hogarty SS, Greenwald DP, Litschge MY, Sandoval LR, Shashidhar G, Guimond S, Keshavan MS, Eack SM. Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial. Psychiatr Serv. 2022 05; 73(5):501-509. PMID: 34470506; PMCID: PMC8888780.
    Citations: 3     Fields:    Translation:Humans
  13. Collin G, Bauer CCC, Anteraper SA, Gabrieli JDE, Molokotos E, Mesholam-Gately R, Thermenos HW, Seidman LJ, Keshavan MS, Shenton ME, Whitfield-Gabrieli S. Hyperactivation of Posterior Default Mode Network During Self-Referential Processing in Children at Familial High-Risk for Psychosis. Front Psychiatry. 2021; 12:613142. PMID: 33633608.
    Citations:    
  14. Seitz-Holland J, Cetin-Karayumak S, Wojcik JD, Lyall A, Levitt J, Shenton ME, Pasternak O, Westin CF, Baxi M, Kelly S, Mesholam-Gately R, Vangel M, Pearlson G, Tamminga CA, Sweeney JA, Clementz BA, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, Crow T, James A, Voineskos A, Buchanan RW, Szeszko PR, Malhotra AK, Rathi Y, Keshavan M, Kubicki M. Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study. Mol Psychiatry. 2021 09; 26(9):5357-5370. PMID: 33483689; PMCID: PMC8329919.
    Citations: 3     Fields:    Translation:Humans
  15. Guimond S, Ling G, Drodge J, Matheson H, Wojtalik JA, Lopez B, Collin G, Brady R, Mesholam-Gately RI, Thermenos H, Eack SM, Keshavan MS. Functional connectivity associated with improvement in emotion management after cognitive enhancement therapy in early-course schizophrenia. Psychol Med. 2022 09; 52(12):2245-2254. PMID: 33183362.
    Citations: 4     Fields:    Translation:Humans
  16. Brady RO, Beermann A, Nye M, Eack SM, Mesholam-Gately R, Keshavan MS, Lewandowski KE. Cerebellar-Cortical Connectivity Is Linked to Social Cognition Trans-Diagnostically. Front Psychiatry. 2020; 11:573002. PMID: 33329111.
    Citations: 4     
  17. Hegde RR, Kelly S, Lutz O, Guimond S, Karayumak SC, Mike L, Mesholam-Gately RI, Pasternak O, Kubicki M, Eack SM, Keshavan MS. Association of white matter microstructure and extracellular free-water with cognitive performance in the early course of schizophrenia. Psychiatry Res Neuroimaging. 2020 11 30; 305:111159. PMID: 32919288.
    Citations: 6     Fields:    Translation:Humans
  18. Oribe N, Hirano Y, Del Re E, Mesholam-Gately RI, Woodberry KA, Ueno T, Kanba S, Onitsuka T, Shenton ME, Spencer KM, Niznikiewicz MA. Longitudinal evaluation of visual P300 amplitude in clinical high-risk subjects: An event-related potential study. Psychiatry Clin Neurosci. 2020 Oct; 74(10):527-534. PMID: 32519778.
    Citations: 11     Fields:    Translation:Humans
  19. Del Re EC, Maekawa T, Mesholam-Gately RI, Wojcik J, Seidman LJ, McCarley RW, Niznikiewicz MA. Abnormal Frequency Mismatch Negativity in Early Psychosis Outpatient Subjects. Clin EEG Neurosci. 2020 Jul; 51(4):207-214. PMID: 31826666.
    Citations:    Fields:    Translation:Humans
  20. Anteraper SA, Collin G, Guell X, Scheinert T, Molokotos E, Henriksen MT, Mesholam-Gately R, Thermenos HW, Seidman LJ, Keshavan MS, Gabrieli JDE, Whitfield-Gabrieli S. Altered resting-state functional connectivity in young children at familial high risk for psychotic illness: A preliminary study. Schizophr Res. 2020 02; 216:496-503. PMID: 31801673; PMCID: PMC7239744.
    Citations: 8     Fields:    Translation:Humans
  21. Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, Seidman LJ, Ball MP, Kern RS, McMahon RP, Robinson J, Marder SR, Keefe RSE. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophr Res Cogn. 2020 Mar; 19:100161. PMID: 31832342; PMCID: PMC6889798.
    Citations: 1     
  22. Fitzsimmons J, Rosa P, Sydnor VJ, Reid BE, Makris N, Goldstein JM, Mesholam-Gately RI, Woodberry K, Wojcik J, McCarley RW, Seidman LJ, Shenton ME, Kubicki M. Cingulum bundle abnormalities and risk for schizophrenia. Schizophr Res. 2020 01; 215:385-391. PMID: 31477373.
    Citations: 10     Fields:    Translation:HumansCells
  23. Kuo SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, Eack SM. Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum. Psychol Med. 2020 07; 50(10):1623-1632. PMID: 31298174; PMCID: PMC9812023.
    Citations: 6     Fields:    Translation:Humans
  24. Kuo SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, Eack SM. Establishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT). Psychiatry Res. 2019 08; 278:116-124. PMID: 31163301; PMCID: PMC9671709.
    Citations:    Fields:    Translation:Humans
  25. Oribe N, Hirano Y, Del Re E, Seidman LJ, Mesholam-Gately RI, Woodberry KA, Wojcik JD, Ueno T, Kanba S, Onitsuka T, Shenton ME, Goldstein JM, Niznikiewicz MA, McCarley RW, Spencer KM. Progressive reduction of auditory evoked gamma in first episode schizophrenia but not clinical high risk individuals. Schizophr Res. 2019 06; 208:145-152. PMID: 31005464.
    Citations: 12     Fields:    Translation:Humans
  26. Hamoda HM, Makhlouf AT, Fitzsimmons J, Rathi Y, Makris N, Mesholam-Gately RI, Wojcik JD, Goldstein J, McCarley RW, Seidman LJ, Kubicki M, Shenton ME. Abnormalities in thalamo-cortical connections in patients with first-episode schizophrenia: a two-tensor tractography study. Brain Imaging Behav. 2019 Apr; 13(2):472-481. PMID: 29667043.
    Citations: 10     Fields:    Translation:Humans
  27. Lyall AE, Savadjiev P, Del Re EC, Seitz J, O'Donnell LJ, Westin CF, Mesholam-Gately RI, Petryshen T, Wojcik JD, Nestor P, Niznikiewicz M, Goldstein J, Seidman LJ, McCarley RW, Shenton ME, Kubicki M. Utilizing Mutual Information Analysis to Explore the Relationship Between Gray and White Matter Structural Pathologies in Schizophrenia. Schizophr Bull. 2019 03 07; 45(2):386-395. PMID: 29618096.
    Citations: 1     Fields:    Translation:Humans
  28. Del Re EC, Bouix S, Fitzsimmons J, Blokland GAM, Mesholam-Gately R, Wojcik J, Kikinis Z, Kubicki M, Petryshen T, Pasternak O, Shenton ME, Niznikiewicz M. Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology. Psychiatry Res. 2019 07; 277:45-51. PMID: 30808608.
    Citations: 6     Fields:    Translation:Humans
  29. Mike L, Guimond S, Kelly S, Thermenos H, Mesholam-Gately R, Eack S, Keshavan M. Social cognition in early course of schizophrenia: Exploratory factor analysis. Psychiatry Res. 2019 02; 272:737-743. PMID: 30832194.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  30. Kline E, Hendel V, Friedman-Yakoobian M, Mesholam-Gately RI, Findeisen A, Zimmet S, Wojcik JD, Petryshen TL, Woo TW, Goldstein JM, Shenton ME, Keshavan MS, McCarley RW, Seidman LJ. A comparison of neurocognition and functioning in first episode psychosis populations: do research samples reflect the real world? Soc Psychiatry Psychiatr Epidemiol. 2019 Mar; 54(3):291-301. PMID: 30488086.
    Citations: 4     Fields:    Translation:Humans
  31. Konishi J, Del Re EC, Bouix S, Blokland GAM, Mesholam-Gately R, Woodberry K, Niznikiewicz M, Goldstein J, Hirayasu Y, Petryshen TL, Seidman LJ, Shenton ME, McCarley RW. Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study. Brain Imaging Behav. 2018 Aug; 12(4):974-988. PMID: 28815390.
    Citations: 1     Fields:    Translation:Humans
  32. Seitz J, Rathi Y, Lyall A, Pasternak O, Del Re EC, Niznikiewicz M, Nestor P, Seidman LJ, Petryshen TL, Mesholam-Gately RI, Wojcik J, McCarley RW, Shenton ME, Koerte IK, Kubicki M. Alteration of gray matter microstructure in schizophrenia. Brain Imaging Behav. 2018 02; 12(1):54-63. PMID: 28102528.
    Citations: 6     Fields:    Translation:Humans
  33. Saito Y, Kubicki M, Koerte I, Otsuka T, Rathi Y, Pasternak O, Bouix S, Eckbo R, Kikinis Z, von Hohenberg CC, Roppongi T, Del Re E, Asami T, Lee SH, Karmacharya S, Mesholam-Gately RI, Seidman LJ, Levitt J, McCarley RW, Shenton ME, Niznikiewicz MA. Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophrenia. Brain Imaging Behav. 2018 02; 12(1):229-237. PMID: 28247157.
    Citations: 9     Fields:    Translation:HumansCells
  34. Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 2018 05; 23(5):1261-1269. PMID: 29038599; PMCID: PMC5984078.
    Citations: 243     Fields:    Translation:Humans
  35. Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, Kahn RS, Roffman JL, Holt DJ, Ehrlich S, Kikinis Z, Dazzan P, Murray RM, Di Forti M, Lee J, Sim K, Lam M, Wolthusen RPF, de Zwarte SMC, Walton E, Cosgrove D, Kelly S, Maleki N, Osiecki L, Picchioni MM, Bramon E, Russo M, David AS, Mondelli V, Reinders AATS, Falcone MA, Hartmann AM, Konte B, Morris DW, Gill M, Corvin AP, Cahn W, Ho NF, Liu JJ, Keefe RSE, Gollub RL, Manoach DS, Calhoun VD, Schulz SC, Sponheim SR, Goff DC, Buka SL, Cherkerzian S, Thermenos HW, Kubicki M, Nestor PG, Dickie EW, Vassos E, Ciufolini S, Reis Marques T, Crossley NA, Purcell SM, Smoller JW, van Haren NEM, Toulopoulou T, Donohoe G, Goldstein JM, Seidman LJ, McCarley RW, Petryshen TL. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophr Res. 2018 05; 195:306-317. PMID: 28982554.
    Citations: 13     Fields:    Translation:Humans
  36. Blokland GAM, Mesholam-Gately RI, Toulopoulou T, Del Re EC, Lam M, DeLisi LE, Donohoe G, Walters JTR, Seidman LJ, Petryshen TL. Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis. Schizophr Bull. 2017 07 01; 43(4):788-800. PMID: 27872257; PMCID: PMC5472145.
    Citations: 25     Fields:    Translation:Humans
  37. Del Re EC, Konishi J, Bouix S, Blokland GA, Mesholam-Gately RI, Goldstein J, Kubicki M, Wojcik J, Pasternak O, Seidman LJ, Petryshen T, Hirayasu Y, Niznikiewicz M, Shenton ME, McCarley RW. Enlarged lateral ventricles inversely correlate with reduced corpus callosum central volume in first episode schizophrenia: association with functional measures. Brain Imaging Behav. 2016 12; 10(4):1264-1273. PMID: 26678596.
    Citations: 15     Fields:    Translation:Humans
  38. Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017 01; 49(1):27-35. PMID: 27869829; PMCID: PMC5737772.
    Citations: 380     Fields:    Translation:Humans
  39. Seitz J, Zuo JX, Lyall AE, Makris N, Kikinis Z, Bouix S, Pasternak O, Fredman E, Duskin J, Goldstein JM, Petryshen TL, Mesholam-Gately RI, Wojcik J, McCarley RW, Seidman LJ, Shenton ME, Koerte IK, Kubicki M. Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia. Schizophr Bull. 2016 May; 42(3):762-71. PMID: 27009248.
    Citations: 21     Fields:    Translation:Humans
  40. Thermenos HW, Juelich RJ, DiChiara SR, Mesholam-Gately RI, Woodberry KA, Wojcik J, Makris N, Keshavan MS, Whitfield-Gabrieli S, Woo TU, Petryshen TL, Goldstein JM, Shenton ME, McCarley RW, Seidman LJ. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis. Schizophr Res. 2016 May; 173(1-2):1-12. PMID: 26965745; PMCID: PMC4836956.
    Citations: 9     Fields:    Translation:Humans
  41. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. PMID: 26896388; PMCID: PMC5410891.
    Citations: 9     Fields:    Translation:Humans
  42. McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychol Med. 2016 Apr; 46(5):1119. PMID: 26537981.
    Citations:    Fields:    
  43. Ohtani T, Bouix S, Lyall AE, Hosokawa T, Saito Y, Melonakos E, Westin CF, Seidman LJ, Goldstein J, Mesholam-Gately R, Petryshen T, Wojcik J, Kubicki M. Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia. Cortex. 2015 Oct; 71:264-76. PMID: 26277547.
    Citations: 10     Fields:    Translation:Humans
  44. McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychol Med. 2015; 45(12):2657-66. PMID: 25916421.
    Citations: 20     Fields:    Translation:Humans
  45. Kikinis Z, Fitzsimmons J, Dunn C, Vu MA, Makris N, Bouix S, Goldstein JM, Mesholam-Gately RI, Petryshen T, Del Re EC, Wojcik J, Seidman LJ, Kubicki M. Anterior commissural white matter fiber abnormalities in first-episode psychosis: a tractography study. Schizophr Res. 2015 Mar; 162(1-3):29-34. PMID: 25667192.
    Citations: 6     Fields:    Translation:Humans
  46. Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Seidman LJ. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):32-7. PMID: 25497440; PMCID: PMC5954831.
    Citations: 10     Fields:    Translation:Humans
  47. Srihari VH, Tek C, Pollard J, Zimmet S, Keat J, Cahill JD, Kucukgoncu S, Walsh BC, Li F, Gueorguieva R, Levine N, Mesholam-Gately RI, Friedman-Yakoobian M, Seidman LJ, Keshavan MS, McGlashan TH, Woods SW. Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study. BMC Psychiatry. 2014 Dec 04; 14:335. PMID: 25471062.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  48. del Re EC, Spencer KM, Oribe N, Mesholam-Gately RI, Goldstein J, Shenton ME, Petryshen T, Seidman LJ, McCarley RW, Niznikiewicz MA. Clinical high risk and first episode schizophrenia: auditory event-related potentials. Psychiatry Res. 2015 Feb 28; 231(2):126-33. PMID: 25557063; PMCID: PMC4314407.
    Citations: 20     Fields:    Translation:Humans
  49. Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophr Res. 2014 Oct; 159(1):182-7. PMID: 25156338.
    Citations: 8     Fields:    Translation:Humans
  50. Fitzsimmons J, Schneiderman JS, Whitford TJ, Swisher T, Niznikiewicz MA, Pelavin PE, Terry DP, Mesholam-Gately RI, Seidman LJ, Goldstein JM, Kubicki M. Cingulum bundle diffusivity and delusions of reference in first episode and chronic schizophrenia. Psychiatry Res. 2014 Nov 30; 224(2):124-32. PMID: 25174840.
    Citations: 11     Fields:    Translation:Humans
  51. Woodberry KA, Serur RA, Hallinan SB, Mesholam-Gately RI, Giuliano AJ, Wojcik JD, Keshavan MS, Frazier JA, Goldstein JM, Shenton ME, McCarley RW, Seidman LJ. Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth. Schizophr Res. 2014 Sep; 158(1-3):45-51. PMID: 24924404.
    Citations: 10     Fields:    Translation:Humans
  52. Oribe N, Hirano Y, Kanba S, Del Re E, Seidman L, Mesholam-Gately R, Goldstein JM, Shenton M, Spencer KM, McCarley RW, Niznikiewicz M. Progressive reduction of visual P300 amplitude in patients with first-episode schizophrenia: an ERP study. Schizophr Bull. 2015 Mar; 41(2):460-70. PMID: 24914176.
    Citations: 10     Fields:    Translation:Humans
  53. Fitzsimmons J, Hamoda HM, Swisher T, Terry D, Rosenberger G, Seidman LJ, Goldstein J, Mesholam-Gately R, Petryshen T, Wojcik J, Kikinis R, Kubicki M. Diffusion tensor imaging study of the fornix in first episode schizophrenia and in healthy controls. Schizophr Res. 2014 Jul; 156(2-3):157-60. PMID: 24837684.
    Citations: 16     Fields:    Translation:HumansCells
  54. Mesholam-Gately RI, Gibson LE, Seidman LJ, Green AI. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine. Schizophr Res. 2014 May; 155(1-3):45-51. PMID: 24685823.
    Citations: 7     Fields:    Translation:Humans
  55. Del Re EC, Bergen SE, Mesholam-Gately RI, Niznikiewicz MA, Goldstein JM, Woo TU, Shenton ME, Seidman LJ, McCarley RW, Petryshen TL. Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds. Transl Psychiatry. 2014 Jan 14; 4:e346. PMID: 24424392.
    Citations: 15     Fields:    Translation:Humans
  56. Francis AN, Seidman LJ, Tandon N, Shenton ME, Thermenos HW, Mesholam-Gately RI, van Elst LT, Tuschen-Caffier B, DeLisi LE, Keshavan MS. Reduced subicular subdivisions of the hippocampal formation and verbal declarative memory impairments in young relatives at risk for schizophrenia. Schizophr Res. 2013 Dec; 151(1-3):154-7. PMID: 24144441.
    Citations: 13     Fields:    Translation:Humans
  57. von Hohenberg CC, Pasternak O, Kubicki M, Ballinger T, Vu MA, Swisher T, Green K, Giwerc M, Dahlben B, Goldstein JM, Woo TU, Petryshen TL, Mesholam-Gately RI, Woodberry KA, Thermenos HW, Mulert C, McCarley RW, Seidman LJ, Shenton ME. White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study. Schizophr Bull. 2014 Jul; 40(4):895-903. PMID: 23737549.
    Citations: 48     Fields:    Translation:Humans
  58. Eack SM, Mesholam-Gately RI, Greenwald DP, Hogarty SS, Keshavan MS. Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy. Psychiatry Res. 2013 Aug 30; 209(1):21-6. PMID: 23623449.
    Citations: 17     Fields:    Translation:Humans
  59. Oribe N, Hirano Y, Kanba S, del Re EC, Seidman LJ, Mesholam-Gately R, Spencer KM, McCarley RW, Niznikiewicz MA. Early and late stages of visual processing in individuals in prodromal state and first episode schizophrenia: an ERP study. Schizophr Res. 2013 May; 146(1-3):95-102. PMID: 23433503.
    Citations: 14     Fields:    Translation:Humans
  60. Quan M, Lee SH, Kubicki M, Kikinis Z, Rathi Y, Seidman LJ, Mesholam-Gately RI, Goldstein JM, McCarley RW, Shenton ME, Levitt JJ. White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia. Schizophr Res. 2013 Apr; 145(1-3):1-10. PMID: 23415471.
    Citations: 42     Fields:    Translation:HumansCells
  61. Lee SH, Kubicki M, Asami T, Seidman LJ, Goldstein JM, Mesholam-Gately RI, McCarley RW, Shenton ME. Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study. Schizophr Res. 2013 Feb; 143(2-3):231-8. PMID: 23290268.
    Citations: 74     Fields:    Translation:Humans
  62. Pasternak O, Westin CF, Bouix S, Seidman LJ, Goldstein JM, Woo TU, Petryshen TL, Mesholam-Gately RI, McCarley RW, Kikinis R, Shenton ME, Kubicki M. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci. 2012 Nov 28; 32(48):17365-72. PMID: 23197727.
    Citations: 153     Fields:    Translation:HumansCells
  63. Francis AN, Seidman LJ, Jabbar GA, Mesholam-Gately R, Thermenos HW, Juelich R, Proal AC, Shenton M, Kubicki M, Mathew I, Keshavan M, Delisi LE. Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res. 2012 Oct; 141(1):65-71. PMID: 22892286.
    Citations: 20     Fields:    Translation:Humans
  64. Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des. 2012; 18(4):399-415. PMID: 22239571.
    Citations: 95     Fields:    Translation:Humans
  65. Mesholam-Gately RI, Giuliano AJ, Zillmer EA, Barakat LP, Kumar A, Gur RC, McAndrew LM, Bilker WB, Elderkin-Thompson V, Moberg PJ. Verbal learning and memory in older adults with minor and major depression. Arch Clin Neuropsychol. 2012 Mar; 27(2):196-207. PMID: 22189596.
    Citations: 6     Fields:    Translation:Humans
  66. Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychol Assess. 2011 Mar; 23(1):245-61. PMID: 21381848.
    Citations: 16     Fields:    Translation:Humans
  67. Rathi Y, Kubicki M, Bouix S, Westin CF, Goldstein J, Seidman L, Mesholam-Gately R, McCarley RW, Shenton ME. Statistical analysis of fiber bundles using multi-tensor tractography: application to first-episode schizophrenia. Magn Reson Imaging. 2011 May; 29(4):507-15. PMID: 21277725.
    Citations: 14     Fields:    Translation:HumansCells
  68. Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res. 2011 Mar; 126(1-3):124-31. PMID: 21159492.
    Citations: 95     Fields:    Translation:Humans
  69. Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, Ball MP, McMahon RP, Kern RS, Robinson J, Marder SR. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry. 2011 Mar 01; 69(5):442-9. PMID: 21145041.
    Citations: 73     Fields:    Translation:Humans
  70. Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res. 2010 Aug; 121(1-3):24-31. PMID: 20542412.
    Citations: 23     Fields:    Translation:Humans
  71. Sponheim SR, Jung RE, Seidman LJ, Mesholam-Gately RI, Manoach DS, O'Leary DS, Ho BC, Andreasen NC, Lauriello J, Schulz SC. Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res. 2010 May; 44(7):421-8. PMID: 19878956.
    Citations: 37     Fields:    Translation:Humans
  72. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009 May; 23(3):315-36. PMID: 19413446.
    Citations: 352     Fields:    Translation:Humans
  73. Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008 Feb; 165(2):214-20. PMID: 18172018.
    Citations: 251     Fields:    Translation:Humans
  74. Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry. 2008 Feb; 165(2):221-8. PMID: 18172017.
    Citations: 100     Fields:    Translation:Humans
  75. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008 Feb; 165(2):203-13. PMID: 18172019.
    Citations: 835     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mesholam-Gately's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (175)
Explore
_
Co-Authors (62)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.